Detection of rat Pneumocystis carinii proteinases and elastase and antipneumocystis activity of proteinase inhibitors in vitro

Parasite

Volumn 6, Issue 1, 1999, Pages 9-16

  Atzori, Chiara ^a   Mainini, A ^a   Agostoni, F ^a   Angeli, E ^a   Bartlett, M ^b   Bruno, A ^c   Scaglia, M ^c   Cargnel, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Elastase; P. carinii proteinases; Proteinase inhibitors

Indexed keywords

PNEUMOCYSTIS CARINII;

ANTIFUNGAL AGENT; ELASTIN; FUNGAL PROTEIN; GELATIN; PANCREATIC ELASTASE; PROTEINASE; PROTEINASE INHIBITOR;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ENZYME SPECIFICITY; ENZYMOLOGY; FEMALE; METABOLISM; PNEUMOCYSTIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIFUNGAL AGENTS; DRUG EVALUATION, PRECLINICAL; ELASTIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOPEPTIDASES; FEMALE; FUNGAL PROTEINS; GELATIN; PANCREATIC ELASTASE; PNEUMOCYSTIS; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTRATE SPECIFICITY;

EID: 0033091048     PISSN: 1252607X     EISSN: None     Source Type: Journal    
DOI: 10.1051/parasite/1999061009     Document Type: Article

References (26)

1. ARROYO R. & AIDERETE J.F. Trichomonas vaginalis surface pro teinase activity is necessary for parasite adherence to epithelial cells. Infection and Immunity, 1989, 57, 2991-2997.
2. ATZORI C., MEANS I.K., BARTLETT M.S., SMITH J.W. & QUEENER S. Detection of P. carinii proteinases using gelatin SDS-PAGE. American Society for Microbiology, Dallas, Texas, 1991, B98.
3. BARTLETT M.S., EICHHOLTZ R. & SMITH J.W. Antimicrobial susceptibility of Pneumocystis carinii in culture. Diagnostic Microbiology and Infectious Diseases, 1985, 3, 381-387.
4. BARTLETT M.S., FISHMAN J.A., QUEENER S.F., DURKIN M.M., JAY M.A. & SMITH J.W. New rat model of Pneumocystis carinii infection. Journal of Clinical Microbiology, 1988, 26, 1100-1103.
5. BARTLETT M.S., QUEENER S.F., TIDWELL R.R., MILHOUS W.K., BERMAN J.D., ELLIS W.Y. & SMITH J.W. 8-Aminoquinolines from Walter Reed Army Institute for Research for treatment and prophylaxis of Pneumocystis pneumonia in rat models. Antimicrobial Agents and Chemotherapy, 1991, 35, 277-282.
6. BOZNER P. & DEMAS P. Degradation of collagen types I, III, IV and V by extracellular proteinases of an oral flagellate Trichomonas tenax. Archives of Oral Biology, 1991, 36, 765-770.
7. FROSCO M., CHASE T. & MACMILLAN J.D. Purification and properties of the elastase from Aspergillus fumigatus. Infection and Immunity, 1992, 60, 728-734.
8. HARTH G., ANDREWS N., MILLS A.A., ENGEL J.C., SMITH R. & MCKERROW J.H. Peptide-fluoromethyl ketones arrest intracellular replication and intracellular transmission of T. cruzi. Molec. Biochem. Parasit., 1993, 58, 17-24.
9. HAYES D.J., STUBBERFIELD C.R., MCBRIDE J.D. & WILSON D.L. Alterations in cysteine proteinase content of rat lung associated with development of Pneumocystis carinii infection. Infection and Immunity, 1991, 59, 3581-3588.
10. IRVINE J.W., COOMBS G.H. & NORTH M.J. Cystatin-like cysteine proteinase inhibitors of parasitic protozoa. FEMS Microbiology Letters, 1992, 75 (1), 67-72.
11. JACKSON P.R., PAPPAS M.G. & HANSEN B.D. Fluorogenic substrate detection of viable intracellular and extracellular pathogenic protozoa. Science, 1985, 227, 435-438.
12. KOTHARY M.H., JR. CHASE T. & MACMILLAN J.D. Correlation of elestase production by some strains of Aspergillus fumigatus with ability to cause pulmonary aspergillosis in mice. Infection and Immunity, 1984, 43, 320-325.
13. KRUGLIAK M. & GINSBURG H. Studies on the antimalarial mode of action of quinoline containing drugs: time dependence and irreversibility of drug action and interaction with compounds that alter the function of the parasite food vacuole. Life Sciences, 1991, 49, 1213-1219.
14. LANE B.R., AST J.C., HOSSLER P.A., MINDELL D.P., BARTLETT M.S., SMITH J.W. & MESHNICK S.R. Diohydropteroate synthase polymorphisms in Pneumocystis carinii. Journal of Infectious Diseases, 1997, 175, 482-485.
15. LEE C.H., BAUER N.L., SHAW M.M., DURKIN M.M., BARTLETT M.S., QUEENER S.F. & SMITH J.W. Proliferation of rat Pneumocystis carinii on cells sheeted on micro carrier beads in spinner flasks. Journal of Clinical Microbiology, 1993, 31, 1659-1662.
16. LOCKWOOD B.C., NORTH M.J., SCOTT K.I.., BREMNER A.F. & COOMBS G.H. The use of a highly sensitive electrophoretic method to compare the proteinases of Trichomonas. Molecular and Biochemical Parasitology, 1987, 24, 89-95.
17. MASSETTI A.P., MENGONI F., CONTINI C., SEBASTIANI G., FOLGORI F., VULLO V. & SORICE F. Characterization and partial purification of P. carinii proteinases. International Congress on Aids and Related Syndromes, Amsterdam, 1992, Po B3310, B138.
18. MERALI S., CHIN K., GRADY R.W., WEISSBERGER L. & CLARKSON A.B. Response of rat model of Pneumocystis carinii pneumonia to continuous infusion of desferoxamine. Antimicrobial Agents and Chemotherapy, 1995, 39, 1442-1444.
19. NORTH M.J., FRANEK J.K. & COTTER D.A. Differential secretion of Dictyostelium discoideum proteinases. Journal of Genetics and Microbiology, 1990, 136, 827-833.
20. POTTRATZ S.T. & MARTIN W.M. Mechanisms of Pneumocystis attachment to cultured rat alveolar macrophages. Journal of Clinical Investigation, 1990, 86, 1678-1693.
21. QUEENER S.F., BARTLETT M.S., NASR M. & SMITH J.W. 8-Aminoquinolines effective against Pneumocystis carinii in vivo and in vitro. Antimicrobial Agents and Chemotherapy, 1993, 37, 2166-2172.
22. SIMONDS R.J., HUGHES W.T., FEINBERG J. & NAVIN T.R. Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus. Clinical Infectious Diseases, 1995, 21, Suppl. 1, S44-S48.
23. STOCKLEY R.A. Chronic bronchitis: the antiproteinase balance and the effect of the infection and corticosteroids. Clinical Chest Medicine, 1988, 9, 643-656.
24. VEENSTRA J., VEUGELERS P.J., KEET I.P.M., VAN DER VEN A.J., MIEDEMA F., LANGE J.M.A. & COUTINHO R.A. Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis. Clinical Infectious Diseases, 1997, 24, 936-941.
25. WEINBERG G.A. Iron chelators as therapeutic agents against Pneumocystis carinii. Antimicrobial Agents and Chemotherapy, 1994, 38, 997-1003.
26. YOUNG R.D. & RATHOD P.K. Clonal viability measurement on Plasmodium falciparum to assess in vitro schizonticidal activity of Leupeptin, Chloroquine and 5-Fluoroorotate. Antimicrobial Agents and Chemotherapy, 1993, 37, 1102-1107.